Challenges for translational psychopharmacology research - Some basic principles

Psychopharmacology

Volumn 199, Issue 3, 2008, Pages 291-301

  Miczek, Klaus A ^a   De Wit, Harriet ^b  

^a TUFTS UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Experimental models; Preclinical findings; Psychiatric disorder

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; DESIPRAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; ECOPIPAM; GABAPENTIN; LEVODOPA; MODAFINIL; NALTREXONE; NEUROLEPTIC AGENT; PERGOLIDE; RISPERIDONE; SELEGILINE; SEROTONIN 1A AGONIST; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ANXIETY DISORDER; COGNITION; CONSTRUCT VALIDITY; COPING BEHAVIOR; DRUG RESEARCH; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; MALADJUSTMENT; NONHUMAN; PARKINSON DISEASE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOPHARMACOLOGY; REVIEW; SYMPTOMATOLOGY; THEORETICAL MODEL; VALIDATION PROCESS; WITHDRAWAL SYNDROME;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; HUMANS; MODELS, PSYCHOLOGICAL; PSYCHOPHARMACOLOGY; RESEARCH DESIGN;

EID: 46649108138     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-008-1198-4     Document Type: Review

References (110)

1. Ahmed SH (2005) Imbalance between drug and non-drug reward availability: a major risk factor for addiction. European J Pharmacol 526:9-20
2. Ahmed SH, Koob GF (1998) Transition from moderate to excessive drug intake: change in hedonic set point. Science 282:298-300
3. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders. American Psychiatric Association, Washington DC
4. Baldo BA, Kelley AE (2007) Discrete neurochemical coding of distinguishable motivational processes: insights from nucleus accumbens control of feeding. Psychopharmacology 191:439-459
5. Barbano MF, Cador M (2007) Opioids for hedonic experience and dopamine to get ready for it. Psychopharmacology 191:497-506
6. Barrett JE, Vanover KE (1993) 5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions. Psychopharmacology 112:1-12
7. Barrett JE, Witkin JM, Mansbach RS, Skolnick P, Weissman BA (1986) Behavioral studies with anxiolytic drugs. III. Antipunishment actions of buspirone in the pigeon do not involve benzodiazepine receptor mechanisms. J Pharmacol Exp Ther 238:1009-1013
8. Berridge KC (2007) The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology 191:391-431
9. Berridge KC, Kringelbach ML (2008) Affective neuroscience of pleasure: reward in humans and animals. Psychopharmacology (in press) DOI 10.1007/s00213-008-1099-6
10. Brady JV (1956) Assessment of drug effects on emotional behavior. Science 123:1033-1034
11. Brain PF (1975) What does individual housing mean to a mouse. Life Sci 16:187-200
12. Burgdorf J, Knutson B, Panksepp J, Shippenberg TS (2001) Evaluation of rat ultrasonic vocalizations as predictors of the conditioned aversive effects of drugs. Psychopharmacology 155:35-42
13. Casper RC, Sullivan EL, Tecott L (2008) Relevance of animal models to human eating disorders and obesity. Psychopharmacology (in press) DOI 10.1007/s00213-008-1102-2
14. Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW, Taylor A, Poulton R (2002) Role of genotype in the cycle of violence in maltreated children. Science 297:851-854
15. Crawley JN, Belknap JK, Collins A, Crabbe JC, Frankel W, Henderson N, Hitzemann RJ, Maxson SC, Miner LL, Silva AJ, Wehner JM, Wynshaw-Boris A, Paylor R (1997) Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology 132:107-124
16. Cryan JF, Markou A, Lucki I (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23:238-245
17. Cryan JF, Valentino RJ, Lucki I (2005) Assessing substrates underlying the behavioral effects of antidepressants using the the modified rat forced swimming test. Neurosci Biobehav Rev 29:547-569
18. Darwin C (1872) The expression of the emotions in man and animals. John Murray, London
19. Davis M, Falls WA, Campeau S, Kim M (1993) Fear-potentiated startle: a neural and pharmacological analysis. Behav Brain Res 58:175-198
20. Deneau G, Yanigita T, Seevers MH (1969) Self-administration of psychoactive substances in the monkey. Psychopharmacologia 16:30-48
21. Deroche-Gamonet V, Belin D, Piazza PV (2004) Evidence for addiction-like behavior in the rat. Science 305:1014-1017
22. Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121:66-72
23. Eagle DM, Bari A, Robbins TW (2008) The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks. Psychopharmacology (in press) DOI 10.1007/s00213-008-1127-6
24. Ernst AM (1967) Mode of action of apomorphine and dexamphetamine in gnawing compulsion in rats. Psychopharmacologia 10:316-323
25. Fahlke C, Lorenz JG, Long J, Champoux M, Suomi SJ, Higley JD (2000) Rearing experiences and stress-induced plasma cortisol as early risk factors for excessive alcohol consumption in nonhuman primates. Alcohol Clin Exp Res 24:644-650
26. Ferrari PF, Van Erp AMM, Tornatzky W, Miczek KA (2003) Accumbal dopamine and serotonin in anticipation of the next aggressive episode in rats. Eur J Neurosci 17:371-378
27. Fischman MW, Foltin RW, Nestadt G, Pearlson GD (1990) Effects of desipramine maintenance on cocaine self-administration by humans. J Pharmacol Exp Ther 253:760-770
28. A receptors. Psychopharmacology 149:277-285
29. Fuller RW (1996) Fluoxetine effects on serotonin function and aggressive behavior. In: Ferris CF (ed) Understanding aggressive behavior in children. The New York Academy of Sciences, New York, New York, pp 90-97
30. Geller I, Seifter J (1960) The effects of meprobamate, barbiturates, d-amphetamine and promazine on experimentally induced conflict in the rat. Psychopharmacologia 1:482-492
31. Geyer MA, Markou A (2002) The role of preclinical models in the development of psychotropic drugs. In: Davis KL, Charney D, Coyle JT, Nemeroff C (eds) Neuropsychopharmacology. The fifth generation of progress. Lippincott Williams & Wilkins, Philadelphia, pp 445-455
32. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156:117-154
33. Gray JA, Mellanby J, Buckland C (1984) Behavioural studies of the role of GABA in anxiolytic drug action. Neuropharmacology 23:827
34. Griebel G (1995) 5-Hydroxtryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol Ther 65:319-395
35. Grill HJ, Norgren R (1978) Taste reactivity test: I. Mimetic responses to gustatory stimuli in neurological normal rats. Brain Res 143:263-279
36. Grillon C (2008) Models and mechanisms of anxiety: evidence from startle studies. Psychopharmacology (in press) DOI 10.1007/s00213-007-1019-1
37. Grillon C, Cordova J, Levine LR, Morgan CA (2003) Anxiolytic effects of a novel group II metabotropic glutamate receptor agonist (LY354740) in the fear-potentiated startle paradigm in humans. Psychopharmacology 168:446-454
38. Haney M, Spealman R (2008) Controversies in translational research: drug self-administration. Psychopharmacology (in press) DOI 10.1007/s00213-008-1079-x
39. Harlow HF, Suomi SJ (1974) Induced depression in monkeys. Behav Biol 12:273-296
40. Hart CL, Ward AS, Collins ED, Haney M, Foltin RW (2004) Gabapentin maintenance decreases smoked cocaine-related subjective effects, but not self-administration by humans. Drug Alcohol Depend 73:279-287
41. Hart CL, Haney M, Vosburg SK, Rubin E, Foltin RW (2008) Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology 33:761-768
42. Helton DR, Tizzano JP, Monn JA, Schoepp DD, Kallman MJ (1998) Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors. J Pharmacol Exp Ther 284:651-660
43. Horovitz ZP, Ragozzino PW, Leaf RC (1965) Selective block of rat mouse-killing by antidepressants. Life Sci 4:1909-1912
44. Horvitz JC (2000) Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events. Neuroscience 96:651-656
45. Huot RL, Thrivikraman KV, Meaney MJ, Plotsky PM (2001) Development of adult ethanol preference and anxiety as a consequence of neonatal maternal separation in Long Evans rats and reversal with antidepressant treatment. Psychopharmacology 158:366-373
46. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F (1997) Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131-141
47. Irwin S (1968) Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia 13:222-257
48. Janssen PAJ, Niemegee CJ, Schellek KH (1965) Is it possible to predict clinical effects of neuroleptic drugs (major tranquillizers) from animal data? I. Neuroleptic activity spectra for rats. Arzneimittelforschung 15:104-117
49. Jenner P, Rupniak NMJ, Rose S, Kelly E, Kilpatrick G, Lees A, Marsden CD (1984) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in the common marmoset. Neurosci Lett 50:85-90
50. Katz RJ, Roth KA, Carroll BJ (1981) Acute and chronic stress effects on open-field activity in the rat - Implications for a model of depression. Neurosci Biobehav Rev 5:247-251
51. Kelleher RT, Morse WH (1968) Determinants of the specificity of behavioral effects of drugs. Ergeb Physiol 60:1-56
52. Kelly JP, Wrynn AS, Leonard BE (1997) The olfactory bulbectomized rat as a model of depression: an update. Pharmacol Ther 74:299-316
53. Koolhaas JM, Korte SM, de Boer SF, Van Der Vegt BJ, Van Reenen CG, Hopster H, De Jong IC, Ruis MAW, Blokhuis HJ (1999) Coping styles in animals: current status in behavior and stress-physiology. Neurosci Biobehav Rev 23:925-935
54. Kornetsky C (1989) Animal models: promises and problems. In: Koob GF (ed) Animal models of depression. Birkhauser, Boston, pp 18-29
55. Kringelbach ML (2008) The hedonic brain: a functional neuroanatomy of human pleasure. In: Kringelbach ML, Berridge KC (eds) Pleasures of the brain. Oxford University Press, Oxford
56. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A (1998) Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19:155-157
57. Lane E, Dunnett S (2008) Animal models of Parkinson's disease and l-dopa induced dyskinesia: how close are we to the clinic? Psychopharmacology (in press) DOI 10.1007/s00213-007-0931-8
58. Lipska BK, Jaskiw GE, Weinberger DR (1993) Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage-a potential animal model of schizophrenia. Neuropsychopharmacology 9:67-75
59. Lipska BK, Swerdlow NR, Geyer MA, Jaskiw GE, Braff DL, Weinberger DR (1995) Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology 122:35-43
60. Markou A, Koob GF (1991) Postcocaine anhedonia-an animal model of cocaine withdrawal. Neuropsychopharmacology 4:17-26
61. McKinney WT, Bunney WE (1969) Animal model of depression. I. Review of evidence-implications for research. Arch Gen Psychiatry 21:240-&
62. Miczek KA (1973) Effects of scopolamine, amphetamine and chlordiazepoxide on punishment. Psychopharmacologia 28:373-389
63. Miczek KA, Haney M, Tidey J, Vivian J, Weerts E (1994) Neurochemistry and pharmacotherapeutic management of violence and aggression. In: Reiss AJ, Miczek KA, Roth JA (eds) Understanding and preventing violence: biobehavioral influences on violence. National Academy, Washington, DC, pp 244-514
64. A and 5-HT anxiolytics. Psychopharmacology 121:38-56
65. Miczek KA, Maxson SC, Fish EW, Faccidomo S (2001) Aggressive behavioral phenotypes in mice. Behav Brain Res 125:167-181
66. Miczek KA, Faccidomo S, de Almeida RMM, Bannai M, Fish EW, DeBold JF (2004) Escalated aggressive behavior: new pharmacotherapeutic approaches and opportunities. Ann N Y Acad Sci 1036:336-355
67. Miczek KA, de Almeida RMM, Kravitz EA, Rissman EF, de Boer SF, Raine A (2007a) Neurobiology of escalated aggression and violence. J Neurosci 27:11803-11806
68. Miczek KA, Faccidomo SP, Fish EW, DeBold JF (2007b) Neurochemistry and molecular neurobiology of aggressive behavior. In: Blaustein J (ed) Behavioral neurochemistry, neuroendocrinology and molecular neurobiology. Springer, New York, pp 285-336
69. Millan MJ (2003) The neurobiology and control of anxious states. Prog Neurobiol 70:83-244
70. Montgomery KC (1955) The relation between fear induced by novel stimulation and exploratory behaviour. J Comp Physiol Psychol 48:254-260
71. Moreau JL, Scherschlicht R, Jenck F, Martin JR (1995) Chronic mild stress-induced anhedonia model of depression-sleep abnormalities and curative effects of electroshock treatment. Behav Pharmacol 6:682-687
72. Mutschler NH, Miczek KA (1998) Withdrawal from a self-administered or non-contingent cocaine binge: differences in ultrasonic distress vocalizations in rats. Psychopharmacology 136:402-408
73. Nordquist RE, Steckler T, Wettstein JG, Mackie C, Spooren W (2008) Metabotropic glutamate receptor modulation, translational methods, and biomarkers: relationship with anxiety. Psychopharmacology (in press) DOI 10.1007/s00213-008-1096-9
74. Pacak K, Palkovits M (2001) Stressor specificity of central neuroendocrine responses: Implications for stress-related disorders. Endocr Rev 22:502-548
75. Panksepp J (2003) At the interface of the affective, behavioral, and cognitive neurosciences: Decoding the emotional feelings of the brain. Brain Cogn 52:4-14
76. Panksepp J, Meeker R, Bean NJ (1980) The neurochemical control of crying. Pharmacol Biochem Behav 12:437-443
77. Phillips AG, Barr AM (1997) Effects of chronic mild stress on motivation for sucrose: mixed messages. Psychopharmacology 134:361-362
78. Porsolt RD, Anton G, Balvet N, Jalfre M (1978) Behavioural despair in rats: new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379-391
79. Reid I, Forbes N, Stewart C, Matthews K (1997) Chronic mild stress and depressive disorder: a useful new model. Psychopharmacology 134:365-367
80. Robbins TW (2002) The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology 163:362-380
81. Robbins TW, Everitt BJ (2007) A role for mesencephalic dopamine in activation: commentary on Berridge (2006). Psychopharmacology 191:433-437
82. Rosenblueth A, Wiener N (1945) The role of models in science. Philosophical Science 12:316-321
83. Routtenberg A, Kuznesof AW (1967) Self-starvation of rats living in activity wheels on a restricted feeding schedule. J Comp Physiol Psychol 64:414-&
84. Salamone JD, Correa M, Farrar A, Mingote SM (2007) Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology 191:461-482
85. Sams-Dodd F, Lipska BK, Weinberger DR (1997) Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood. Psychopharmacology 132:303-310
86. Sanger DJ (1985) GABA and the behavioral effects of anxiolytic drugs. Life Sci 36:1503-1513
87. Sanger DJ (1992) Increased rates of punished responding produced by buspirone-like compounds in rats. J Pharmacol Exper Ther 261:513-517
88. Schuster CR (1975) Drugs as reinforcers in monkey and man. Pharmacol Rev 27:511-521
89. Scott DJ, Heitzeg MM, Koeppe RA, Stohler CS, Zubieta JK (2006) Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine activity. J Neurosci 26:10789-10795
90. Spooren WP, Gasparini F, Salt TE, Kuhn R (2001) Novel allosteric antagonists shed light on mGlu(5) receptors and CNS disorders. Trends Pharmacol Sci 22:331-337
91. Steiner JE, Glaser D, Hawilo ME, Berridge KC (2001) Comparative expression of hedonic impact: affective reactions to taste by human infants and other primates. Neurosci Biobehav Rev 25:53-74
92. Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test-a new method for screening antidepressants in mice. Psychopharmacology 85:367-370
93. Suomi SJ, Eisele CD, Grady SA, Harlow HF (1975) Depressive behavior in adult monkeys following separation from family environment. J Abnorm Psychol 84:576-578
94. Turri MG, Datta SR, DeFries J, Henderson ND, Flint J (2001) QTL analysis identifies multiple behavioral dimensions in ethological tests of anxiety in laboratory mice. Curr Biol 11:725-734
95. Ungerstedt U (1971a) Adipsia and aphagia after 6-hydroxydopamine induced degeneration of nigro-striatal dopamine system. Acta Physiol Scand Suppl 367:95-122
96. Ungerstedt U (1971b) Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 367:69-93
97. Valzelli L (1973) The "Isolation syndrome" in mice. Psychopharmacologia 31:305-320
98. Vanderschuren LJ, Everitt BJ (2004) Drug seeking becomes compulsive after prolonged cocaine self-administration. Science 305:1017-1019
99. Vitiello B, Stoff DM (1997) Subtypes of aggression and their relevance to child psychiatry. J Am Acad Child Adolesc Psychiatry 36:307-315
100. Vivian JA, Barros HMT, Manitiu A, Miczek KA (1997) Ultrasonic vocalizations in rat pups: modulation at the gamma-aminobutyric acidA receptor complex and the neurosteroid recognition site. J Pharmacol Exp Ther 282:318-325
101. Vogel JR, Beer B, Clody DE (1971) A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia 21:1-7
102. Weiss JM, Kilts CD (1995) Animal models of depression and schizophrenia. In: Schatzberg AF (ed) The American psychiatric press textbook of psychopharmacology. American Psychiatric Press, Washington DC, pp 81-123
103. Willner P (1984) The validity of animal models of depression. Psychopharmacology 83:1-16
104. Willner P (1997) Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 134:319-329
105. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R (1987) Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 93:358-364
106. Winslow JT, Insel TR (1991) Infant rat separation is a sensitive test for novel anxiolytics. Prog Neuropsychopharmacol Biol Psychiatry 15:745-757
107. Wise RA (2006) Role of brain dopamine in food reward and reinforcement. Philos Trans R Soc Lond B Biol Sci 361:1149-1158
108. Wise RA, Bauco P, Carlezon WA, Trojniar W (1992) Self-stimulation and drug reward mechanisms. Ann N Y Acad Sci 654:192-198
109. Wuttke W, Kelleher RT (1970) Effects of some benzodiazepines on punished and unpunished behavior in the pigeon. J Pharmacol Exp Ther 172:397-405
110. 1B receptors. Neuropsychopharmacology 21:S52-S60